Mathias Haag
Research Group Leader Pharmacometabolomics

Dr. Mathias Haag

Major Projects

  • Quantitative profiling of bile acids during clinical drug development
  • Identification and analysis of novel predictors for the prognosis and/or therapy of kidney cancer

Selected References

Curriculum Vitae

Education and Professional Career

since 2013

Senior scientist at the Dr. Margarete Fischer-Bosch-Institute for Clinical Pharmacology in Stuttgart, Germany (Prof. Dr. Matthias Schwab): “Mass Spectrometry-Based Targeted and Non-Targeted Metabolomics and Lipidomics”


Postdoctoral fellow at the Institute for Genetics of the University of Cologne, Germany (Prof. Dr. Thomas Langer): “Establishment of Mass Spectrometric Methods for the Quantification of Mitochondrial Phospholipids”


PhD thesis and postdoctoral fellow at the Heidelberg University Biochemistry Center in Heidelberg, Germany (Prof. Dr. Felix Wieland and PD. Dr. Britta Brügger): “Development of Mass Spectrometric Methods for the Quantification of Membrane Lipids – Studies on Mitochondria, T Cells, Golgi Membranes and COPI Vesicles”


Diploma thesis in the Preclinical R&D Department at Merck KGaA in Darmstadt, Germany (Dr. Roland Kellner): “Characterization of Native and Recombinant Allergens with Protein Analytical Methods”


Studies in Biotechnology at the University of Applied Sciences in Darmstadt, Germany